The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…

Startups Chasing the $100 Billion Market for Weight-Loss Drugs

Kristen Coletto, Aetion, on using Real World Evidence to accelerate drug discovery and commercialization by The Pulse by Wharton Digital Health

Calibrate taps new CEO, unveils partnership with OptumRx

2021 Review of Funding for Female Founders, by Female Founders Fund

Prescription Weight Loss Drugs for Obesity Work—If Your Doctor Lets You Get Them - Bloomberg

Isabelle Kenyon - Calibrate

Marina Tarasova, Paloma Health, on modernizing thyroid care by The Pulse by Wharton Digital Health

Advice for raising capital from 21 top founders who raised over $500M

Ep439: Isabelle Kenyon, Founder & CEO, Calibrate, Ep439: Isabelle Kenyon

Weight-Loss Startup Calibrate Sells to Madryn Asset Management